Device type · JIN
Nitroprusside, Ketones (Urinary, Non-Quant.)
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JIN
Clinical Chemistry
Device class
Class I
FDA decisions since 2015
6
510(k), De Novo and PMA
Adverse event reports
3
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Nitroprusside, Ketones (Urinary, Non-Quant.)
- Product code
- JIN
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1435
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JIN
Latest FDA decisions
K201551 · Decided Sep 9, 2020 · 92 days after receipt
Device type: Nitroprusside, Ketones (Urinary, Non-Quant.) (JIN) · Laboratory Medicine & Pathology
Vivachek Biotech (Hangzhou) Co., Ltd.
K192957 · Decided Jun 5, 2020 · 228 days after receipt
Device type: Nitroprusside, Ketones (Urinary, Non-Quant.) (JIN) · Laboratory Medicine & Pathology
K182593 · Decided Dec 18, 2018 · 89 days after receipt
Device type: Nitroprusside, Ketones (Urinary, Non-Quant.) (JIN) · Laboratory Medicine & Pathology
K173345 · Decided May 4, 2018 · 192 days after receipt
Device type: Nitroprusside, Ketones (Urinary, Non-Quant.) (JIN) · Laboratory Medicine & Pathology
K170463 · Decided Apr 13, 2018 · 422 days after receipt
Device type: Nitroprusside, Ketones (Urinary, Non-Quant.) (JIN) · Laboratory Medicine & Pathology
K170587 · Decided Jul 6, 2017 · 128 days after receipt
Device type: Nitroprusside, Ketones (Urinary, Non-Quant.) (JIN) · Laboratory Medicine & Pathology
Reports received
3
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
3
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 1 | 0 | 0 | 0 |
| Mar 24 | 2 | 0 | 0 | 0 |
| Apr 24 | 1 | 0 | 0 | 0 |
| May 24 | 2 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 1 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 1 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 2 | 0 | 0 | 0 |
| Feb 26 | 1 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Product Quality Problem3
- Component Missing2
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions3
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- One Step K in vitro diagnostic test REF: 81A4Open, Classified
Z-2087-2026 · Started Apr 2, 2026 · Posted by FDA May 6, 2026
Reason given: The devices were distributed without required FDA premarket clearance or approval.
Cause as FDA categorized it: No Marketing Application
Changchun Wancheng Bio-Electron Co., Ltd.
Z-1258-2026 · Started Nov 22, 2025 · Posted by FDA Feb 4, 2026
Reason given: Test strips and other tests including for near-patient testing, that require a 510(k) were distributed before they could be legally marketed to U.S. customers; devices may cause false or inaccurate diagnostic result by lay person and lead to inappropriate medical intervention.
Cause as FDA categorized it: No Marketing Application
- STAT-Site M BHB Test Strips, used with STAT-SITE M Beta-HB Meter as an in vitro diagnostic for blood ketone values.Open, Classified
Z-0490-2024 · Started Oct 2, 2023 · Posted by FDA Dec 6, 2023
Reason given: Deterioration in the stability of the Test Strips results in diminished low-range detection capability and inability to meet linearity performance claims. The root cause of the stability deterioration in is identified as the change in material that caused a pH shift in the coating solution resulting in precipitation...
Cause as FDA categorized it: Component change control
Z-0046-2024 · Started May 22, 2023 · Posted by FDA Oct 23, 2023
Reason given: Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business...
Cause as FDA categorized it: Other
- PrestiBio KETONE TEST STRIPS REF 900-1KET 100 STRIPS/+50 FREEOpen, Classified
Z-0056-2024 · Started May 22, 2023 · Posted by FDA Oct 23, 2023
Reason given: Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business...
Cause as FDA categorized it: Other
- Hydroxybutyrate LiquiColor Tests - includes 3 bottles (1 of each size, 3mL, 8.5mL, and 50mL)Terminated
MEDLINE INDUSTRIES, LP - Northfield
Z-0932-2022 · Started Mar 8, 2022
Reason given: Product was improperly store which may cause a delay in results.
Cause as FDA categorized it: Storage
Z-2199-2021 · Started Jul 12, 2021
Reason given: Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Quality Control values.
Cause as FDA categorized it: Under Investigation by firm
Z-2200-2021 · Started Jul 12, 2021
Reason given: Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Quality Control values.
Cause as FDA categorized it: Under Investigation by firm
Showing the 8 newest of 14 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.